Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Endometrial Neoplasms × enfortumab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Muscle-invasive Bladder Cancer 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Solid Tumor 1 Advanced Bladder Cancer 1

Interventions

Paclitaxel 8 Carboplatin 6 Tirzepatide 3 Observation 3 Cisplatin 3 dostarlimab 2 Progestins 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Bevacizumab 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 semaglutide 1 pembrolizumab 1 olaparib 1 montelukast 1 enfortumab vedotin 1 bemarituzumab 1 apatinib 1 Watchful Waiting 1 Vaginal Smears 1 Topotecan 1 Tablets 1 Specimen Handling 1 Sensitivity Training Groups 1 Resistance Training 1 Platinum 1 Palliative Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07139977 2026-01-20

EV-4-EC

Medical College of Wisconsin

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡